SUMMARY Acute hypoglycaemia (<2.0 mmoLll) selectively increased in vitro 3-0-methylglucose uptake by rat jejunum. In contrast, uptake of 3H-phenylalanine or 59Fe (III) was unchanged in the hypoglycaemic animals. The hypoglycaemia was accompanied by decreased tissue adenosine nucleotide energy charge. The increased uptake was phlorrhidzin-inhibitable and therefore reflected increased Na+ dependent glucose carrier activity. Cycloheximide did not block the increased 3-O-methylglucose uptake, implying that the mechanism is not the result of increased de novo carrier protein synthesis.
Rats rendered chronically diabetic show various changes in small intestinal function and structure including enhanced sugar transport, increased activities of brush border hydrolases and of glycolytic enzymes, depressed calcium absorption and, in the longer term, morphological changes.'.
Early studies in alloxan induced diabetes in rats indicated that glucose absorption was accelerated in diabetes and this effect was prevented by insulin. ' 3-U-methyl D-glucose absorption by isolated perfused jejunal segments was also increased in alloxan induced diabetes and in rats where diabetes was induced by anti-insulin serum.' Another study confirmed increased intestinal glucose absorption in streptozotocin induced diabetes, but with a less marked rise in glucose absorption in anti-insulin serum induced diabetes.' There was no change in glucose absorption when insulin was added to the media.
A study carried out in man also showed that intestinal glucose absorption was significantly greater in diabetic than in normal subjects. Insulin administration did not alter glucose absorption in either patient group, even though it always depressed the blood glucose.7 In contrast, starvation induced hypoglycaemia in the rat produced accelerated glucose absorption by everted sacs of rat upper ileum.' Little is known, however, of the mechanism of the hypoglycaemic response. We have therefore characterised and used an in vitro technique for determining 3-0-methylglucose transport by isolated jejunal tissue slices and investigated the changes after insulin induced hypoglycaemia.
Methods

ANIMALS
Five week old male Sprague-Dawley rats (140-160 g) were used throughout. They were fed a standard rodent diet (Labsure LAD 1 diet Lavender Hill, Manea, Cambridgeshire).
IN VITRO UPTAKE
The technique used has been fully validated for use with a variety of nutrients.7 "' In particular, ''Cr EDTA has been shown in several studies to be an excellent choice for an extracellular marker when measuring 3-0-methylglucose uptake." '4 In brief, a piece of intestinal tissue was removed 3 cm distal to the duodenojejunal junction, cut longitudinally and sectioned into fragments (5-15 mg wet weight). After a brief rinse in buffered HEPES (N-2-hydroxyethanepiperazine N-2 ethane sulphonic acid)-oxygenated medium ( Figure 3 . Both the low and high doses of insulin produced a fall in the blood glucose over the first 10 to 15 min followed by recovery phase. In vitro jejunal glucose uptake was assayed at 15, 30, and 60 min after the insulin injections and showed Michaelis Menten kinetics (Fig. 4) Figure 4 : in both apparent Km does not apply, although Debnam and ind insulin treated animals uptake was fully Levin'`claimed that the true Km for active absorpby ouabain. Intestinal 3 MG uptake in tion for a variety of sugars is about three times less reated animals in whom blood glucose levels than that of the apparent Km, the 5'Cr permeability Amped' also showed saturation kinetics but probe has been shown in many subsequent studies to tic parameters did not differ from control correct for this. '4 ( Table 1) .
The results in the insulin+glucose treated rats )ecificity of the response to insulin infusion which show no change in the 3 MG uptake indicates stigated by estimating "'Fe (III) and [ HJ-that hypoglycaemia per se and not the increased anine uptake in tvitro. As seen in Table 2 no plasma insulin level is the mediator of the enhanced it differences were found between the 3 MG uptake. To confirm this it would be necessary and the insulin treated groups. Intestinal to carry out further studies to exclude other factors -)take in insulin treated and control animals for example, hyperglucagonaemia, as concentrations ith cycloheximide are shown in Table 1 . The of pancreatic glucagon would be expected to rise 13 MG uptake in the hypoglycaemic animals during acute hypoglycaemia.' When glucagon (1 Rg) cyclohexamide were similar to that seen in was administered iv in control animals, however, no receiving insulin alone. When cycloheximide change in intestinal glucose uptake was observed. inistered to control animals no blood glucose No changes in 3 MG uptake were seen when were seen within the first two hours. Insulin jejunal slices were incubated with the medium conrats had reduced ATP levels and energy taining 1000 U/l insulin. This also suggests that the Table 1 Intestinal 3-0-mneti v/gluclose uptake 30 minutes after 5 Ulkg insulin undet-r s'arious expverimential conditions. The failure of cycloheximide to prevent the 
